Biopharma Leads Healthcare Portfolio 2020-2021
January 19, 2021 at 13:47 PM EST
Clearly, biopharma stocks, both large and small, led the way to outperformance within healthcare. But Q4 2020 was very speculative, so we expect that the momentum will ebb in 2021 in a shift to large-caps.